UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT)

Circulation (New York, N.Y.), 2011-09, Vol.124 (11), p.1250-1259

ACT Investigators

2011

Volltextzugriff (PDF)

Implantable cardioverter-defibrillator prescription in the elderly

Heart rhythm, 2009-08, Vol.6 (8), p.1136-1143

2009

Volltextzugriff (PDF)

Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS

Neurology, 2009-02, Vol.72 (6), p.535-541

2009

Volltextzugriff (PDF)

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

The Lancet (British edition), 2022-07, Vol.400 (10347), p.161-169

2022

Volltextzugriff (PDF)

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

The lancet oncology, 2017-10, Vol.18 (10), p.1373-1385

2017

Volltextzugriff (PDF)

Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)

Circulation. Heart failure, 2017-06, Vol.10 (6)

2017

Volltextzugriff (PDF)

Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy

Trials, 2009-06, Vol.10 (38), p.38-38, Article 38

2009

Volltextzugriff (PDF)

Machine learning to predict rapid progression of carotid atherosclerosis in patients with impaired glucose tolerance

EURASIP journal on bioinformatics & systems biology, 2016-12, Vol.2016 (1), p.14-7, Article 14

2016

Volltextzugriff (PDF)

Abstract 15947: Machine Learning to Predict Rapid Progression of Carotid Atherosclerosis in Patients With Impaired Glucose Tolerance in the ACT NOW Study

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A15947-A15947

2015

Volltextzugriff (PDF)

Adapting hypertension self-management interventions to enhance their sustained effectiveness among urban African Americans

Family & community health, 2014-04, Vol.37 (2), p.119-133

2014

Volltextzugriff (PDF)

Usefulness of Vernakalant Hydrochloride Injection for Rapid Conversion of Atrial Fibrillation

The American journal of cardiology, 2010-11, Vol.106 (9), p.1277-1283

2010

Volltextzugriff (PDF)

Compliance, persistence, and preference outcomes of postmenopausal osteoporotic women receiving a flexible or fixed regimen of daily risedronate: A multicenter, prospective, parallel group study

Acta orthopaedica et traumatologica turcica, 2015, Vol.49 (1), p.67

2015

Volltextzugriff (PDF)

Sex and outcomes after stenting and endarterectomy in asymptomatic severe carotid stenosis patients

Journal of stroke and cerebrovascular diseases, 2024-11, Vol.33 (11), p.108004, Article 108004

2024

Volltextzugriff (PDF)

PSYCHOMETRICALLY-DEFINED LATE-ONSET ALZHEIMER’S DISEASE (LOAD) SUBGROUPS IN 5 STUDIES (TOTAL N = 4,170): PREVALENCE AT FIRST VISIT, ASSOCIATIONS WITH APOE GENOTYPE AND IGAP SNPS, AND GWAS

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P1488-P1488

2017

Volltextzugriff (PDF)

Effect of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), on blood pressure in patients with mild to moderate hypertension - a large Aceon® Community Trial (ACT) with 8083 patients

American journal of hypertension, 2002, Vol.15 (4), p.A41-A41

2002

Volltextzugriff (PDF)

Effect of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in the treatment of 1022 African-American patients with mild to moderate hypertension: subgroup analysis of a 12 week, open-label, Aceon®Community Trial (ACT)

American journal of hypertension, 2002, Vol.15 (4), p.A40-A41

2002

Volltextzugriff (PDF)

Efficacy and safety of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in 2269 elderly hypertensive patients: subgroup analysis of a 12-week, open-label, Aceon® Community Trial (ACT)

American journal of hypertension, 2002, Vol.15 (4), p.A41-A41

2002

Volltextzugriff (PDF)

Efficacy and safety of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in 899 hypertensive patients on oral hypoglycemic agents - subgroup analysis of a 12-week, open-label, aceon® Community Trial (ACT)

American journal of hypertension, 2002, Vol.15 (4), p.A42-A42

2002

Volltextzugriff (PDF)

RSD1235 for conversion of atrial fibrillation. The phase III atrial arrhythmia conversion trial

Heart rhythm, 2005-09, Vol.2 (9), p.1035-1035

2005

Volltextzugriff (PDF)

RSD1235 in the Treatment of Recent Onset Atrial Fibrillation in ACT I, (Atrial Arrhythmia Conversion Trial I) - Effect of Age, Sex, and Prior Rate Control Medications

Annals of emergency medicine, 2005-09, Vol.46 (3), p.115-115

2005

Volltextzugriff (PDF)

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial

Critical care medicine, 2004-02, Vol.32 (2), p.332-341

2004

Volltextzugriff (PDF)

Rheumatoid arthritis - treatment: 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis

Rheumatology (Oxford, England), 2011-04, Vol.50 (Supplement 3), p.iii111-iii129

2011

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT)

Implantable cardioverter-defibrillator prescription in the elderly

Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)

Abstract WMP11: Health-related Quality Of Life After Thrombolysis In Acute Stroke: Results From The Act Trial

Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy

Machine learning to predict rapid progression of carotid atherosclerosis in patients with impaired glucose tolerance

Abstract 15947: Machine Learning to Predict Rapid Progression of Carotid Atherosclerosis in Patients With Impaired Glucose Tolerance in the ACT NOW Study

Adapting hypertension self-management interventions to enhance their sustained effectiveness among urban African Americans

Usefulness of Vernakalant Hydrochloride Injection for Rapid Conversion of Atrial Fibrillation

Compliance, persistence, and preference outcomes of postmenopausal osteoporotic women receiving a flexible or fixed regimen of daily risedronate: A multicenter, prospective, parallel group study

Sex and outcomes after stenting and endarterectomy in asymptomatic severe carotid stenosis patients

PSYCHOMETRICALLY-DEFINED LATE-ONSET ALZHEIMER’S DISEASE (LOAD) SUBGROUPS IN 5 STUDIES (TOTAL N = 4,170): PREVALENCE AT FIRST VISIT, ASSOCIATIONS WITH APOE GENOTYPE AND IGAP SNPS, AND GWAS

Effect of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), on blood pressure in patients with mild to moderate hypertension - a large Aceon® Community Trial (ACT) with 8083 patients

Effect of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in the treatment of 1022 African-American patients with mild to moderate hypertension: subgroup analysis of a 12 week, open-label, Aceon®Community Trial (ACT)

Efficacy and safety of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in 2269 elderly hypertensive patients: subgroup analysis of a 12-week, open-label, Aceon® Community Trial (ACT)

Efficacy and safety of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in 899 hypertensive patients on oral hypoglycemic agents - subgroup analysis of a 12-week, open-label, aceon® Community Trial (ACT)

RSD1235 for conversion of atrial fibrillation. The phase III atrial arrhythmia conversion trial

RSD1235 in the Treatment of Recent Onset Atrial Fibrillation in ACT I, (Atrial Arrhythmia Conversion Trial I) - Effect of Age, Sex, and Prior Rate Control Medications

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial

Rheumatoid arthritis - treatment: 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis

Aktive Filter

Suchergebnisse filtern